Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 11 articles:
HTML format
Text format



Single Articles


    September 2016
  1. SIMONSSON M, Bjorner S, Markkula A, Nodin B, et al
    The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30432.
    PubMed     Text format     Abstract available


    February 2016
  2. WANG Z, Butler LM, Wu AH, Koh WP, et al
    Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30024.
    PubMed     Text format     Abstract available


    August 2015
  3. KATO I, Chlebowski RT, Hou L, Wactawski-Wende J, et al
    Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29819.
    PubMed     Text format     Abstract available


  4. ROMAN M, Sakshaug S, Graff-Iversen S, Vangen S, et al
    Postmenopausal hormone therapy and the risk of breast cancer in Norway.
    Int J Cancer. 2015 Aug 20. doi: 10.1002/ijc.29810.
    PubMed     Text format     Abstract available


    April 2015
  5. KOSKELA-NISKA V, Pukkala E, Lyytinen H, Ylikorkala O, et al
    Postmenopausal hormone therapy - also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.
    Int J Cancer. 2015 Apr 4. doi: 10.1002/ijc.29549.
    PubMed     Text format     Abstract available


    February 2015
  6. FORTNER RT, Ose J, Merritt MA, Schock H, et al
    Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness, and histologic subtypes: Results from the EPIC cohort.
    Int J Cancer. 2015 Feb 5. doi: 10.1002/ijc.29471.
    PubMed     Text format     Abstract available


    December 2014
  7. HUANG Z, Gao Y, Wen W, Li H, et al
    Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai women's health study.
    Int J Cancer. 2014 Dec 29. doi: 10.1002/ijc.29412.
    PubMed     Text format     Abstract available


  8. KOTSOPOULOS J, Lubinski J, Gronwald J, Cybulski C, et al
    Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Int J Cancer. 2014 Dec 6. doi: 10.1002/ijc.29386.
    PubMed     Text format     Abstract available


    November 2014
  9. WARGON V, Riggio M, Giulianelli S, Sequeira GR, et al
    Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Int J Cancer. 2014 Nov 1. doi: 10.1002/ijc.29304.
    PubMed     Text format     Abstract available


    September 2014
  10. FELIX AS, Gaudet MM, Vecchia CL, Nagle CM, et al
    Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
    Int J Cancer. 2014 Sep 20. doi: 10.1002/ijc.29229.
    PubMed     Text format     Abstract available


    July 2014
  11. ZAMORA-ROS R, Rinaldi S, Biessy C, Tjonneland A, et al
    Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study.
    Int J Cancer. 2014 Jul 8. doi: 10.1002/ijc.29067.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: